Stéphane Zuily

4.8k total citations
114 papers, 2.1k citations indexed

About

Stéphane Zuily is a scholar working on Rheumatology, Hematology and Surgery. According to data from OpenAlex, Stéphane Zuily has authored 114 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 66 papers in Rheumatology, 35 papers in Hematology and 29 papers in Surgery. Recurrent topics in Stéphane Zuily's work include Systemic Lupus Erythematosus Research (64 papers), Platelet Disorders and Treatments (28 papers) and Venous Thromboembolism Diagnosis and Management (16 papers). Stéphane Zuily is often cited by papers focused on Systemic Lupus Erythematosus Research (64 papers), Platelet Disorders and Treatments (28 papers) and Venous Thromboembolism Diagnosis and Management (16 papers). Stéphane Zuily collaborates with scholars based in France, United States and Belgium. Stéphane Zuily's co-authors include Denis Wahl, Doruk Erkan, Virginie Dufrost, Véronique Regnault, Ozan Ünlü, Katrien Devreese, Jessie Risse, Bas de Laat, Thomas Lecompte and Vittorio Pengo and has published in prestigious journals such as Circulation, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Stéphane Zuily

108 papers receiving 2.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Stéphane Zuily France	29	1.4k	866	429	331	327	114	2.1k
Claudine Caron France	24	500 0.4×	1.4k 1.6×	388 0.9×	233 0.7×	227 0.7×	68	2.3k
Françoise Boehlen Switzerland	26	470 0.3×	1.2k 1.4×	290 0.7×	386 1.2×	160 0.5×	96	2.3k
Emmanuel de Maistre France	22	466 0.3×	630 0.7×	375 0.9×	529 1.6×	100 0.3×	69	1.8k
Sara De Carolis Italy	25	997 0.7×	648 0.7×	279 0.7×	234 0.7×	131 0.4×	114	2.4k
F. Baudo Italy	27	712 0.5×	3.1k 3.6×	494 1.2×	325 1.0×	141 0.4×	74	3.9k
Doris Barcellona Italy	16	548 0.4×	496 0.6×	208 0.5×	365 1.1×	81 0.2×	62	1.2k
William L. Nichols United States	29	277 0.2×	1.8k 2.0×	552 1.3×	372 1.1×	216 0.7×	67	2.5k
P de Moerloose Switzerland	22	413 0.3×	665 0.8×	309 0.7×	518 1.6×	87 0.3×	64	1.8k
Mehdi Khellaf France	26	245 0.2×	1.6k 1.8×	288 0.7×	131 0.4×	138 0.4×	73	2.3k
J. Mark Sloan United States	27	212 0.2×	510 0.6×	387 0.9×	150 0.5×	175 0.5×	143	2.4k

Countries citing papers authored by Stéphane Zuily

Since Specialization

Citations

This map shows the geographic impact of Stéphane Zuily's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stéphane Zuily with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stéphane Zuily more than expected).

Fields of papers citing papers by Stéphane Zuily

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stéphane Zuily. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stéphane Zuily. The network helps show where Stéphane Zuily may publish in the future.

Co-authorship network of co-authors of Stéphane Zuily

This figure shows the co-authorship network connecting the top 25 collaborators of Stéphane Zuily. A scholar is included among the top collaborators of Stéphane Zuily based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stéphane Zuily. Stéphane Zuily is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Klein, Thomas, et al.. (2025). Reduced symptoms of anxiety among professional caregivers facing cardiac arrest after simulation based training. Scientific Reports. 15(1). 9406–9406.

Mahé, Guillaume, F. Thony, Stéphane Zuily, et al.. (2024). Venous recanalisation in the setting of post-thrombotic syndrome: An expert consensus from the French Society of Vascular Medicine (SFMV) and the French Society of Cardiovascular Imaging and Interventional Radiology (SFICV). JMV-Journal de Médecine Vasculaire. 49(3-4). 141–161. 1 indexed citations

Dufrost, Virginie, et al.. (2024). Epidemiology, natural history, diagnosis, and management of ovarian vein thrombosis: a scoping review. Journal of Thrombosis and Haemostasis. 22(11). 2991–3003. 3 indexed citations

Dufrost, Virginie, Jérémy Lagrange, Guillaume Mourey, et al.. (2024). Thrombin Generation Assay in Antiphospholipid Antibodies Positive Subjects as a Personalized Thrombotic Risk Assessment: State of the Art and Perspectives. Current Rheumatology Reports. 26(5). 178–187. 2 indexed citations

Lévy, Bruno, et al.. (2024). Manual versus automatic chest compression devices for cardiopulmonary resuscitation under zero gravity (The MACCC - 0G STUDY). Resuscitation. 203. 110385–110385. 1 indexed citations

Barbhaiya, Medha, Stéphane Zuily, María Laura Bertolaccini, et al.. (2023). Response to: Correspondence on ‘ACR/EULAR antiphospholipid syndrome classification criteria’ by Damoiseaux and van Beers. Annals of the Rheumatic Diseases. 83(3). e7–e8. 7 indexed citations

Erkan, Doruk, Medha Barbhaiya, Stéphane Zuily, et al.. (2023). Response to: Correspondence on ‘2023 ACR/EULAR antiphospholipid syndrome classification criteria’ by Miro-Mur et al. Annals of the Rheumatic Diseases. 83(3). e3–e4. 3 indexed citations

Zuily, Stéphane, et al.. (2023). Thrombocytopenia in antiphospholipid syndrome: Is anticoagulation and/or antiaggregation always required?. Autoimmunity Reviews. 23(1). 103417–103417. 9 indexed citations

Barbhaiya, Medha, Stéphane Zuily, Vinicius Domingues, et al.. (2023). Efforts to Better Characterize “Antiphospholipid Antibody Nephropathy” for the 2023 ACR/EULAR Antiphospholipid Syndrome Classification Criteria: Renal Pathology Subcommittee Report. The Journal of Rheumatology. 51(2). 150–159. 20 indexed citations

10.

Olivera, Pablo A., Juan S. Lasa, Giovanni Peretto, et al.. (2023). Review article: Risk of cardiovascular events in patients with inflammatory bowel disease receiving small molecule drugs. Alimentary Pharmacology & Therapeutics. 57(11). 1231–1248. 26 indexed citations

11.

Chayouâ, Walid, Bas de Laat, Gary Moore, et al.. (2022). Added value of antiphosphatidylserine/prothrombin antibodies in the workup of thrombotic antiphospholipid syndrome: Communication from the ISTH SSC Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibodies. Journal of Thrombosis and Haemostasis. 20(9). 2136–2150. 32 indexed citations

12.

Chayouâ, Walid, Bas de Laat, Jean‐Christophe Gris, et al.. (2021). Semiquantitative interpretation of anticardiolipin and antiβ2glycoprotein I antibodies measured with various analytical platforms: Communication from the ISTH SSC Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibodies. Journal of Thrombosis and Haemostasis. 20(2). 508–524. 40 indexed citations

13.

Zuily, Stéphane, Hannah Cohen, David Isenberg, et al.. (2020). Use of direct oral anticoagulants in patients with thrombotic antiphospholipid syndrome: Guidance from the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis. Journal of Thrombosis and Haemostasis. 18(9). 2126–2137. 89 indexed citations

14.

Chayouâ, Walid, Hilde Kelchtermans, Philip G. de Groot, et al.. (2019). Detection of anti‐domain I antibodies by chemiluminescence enables the identification of high‐risk antiphospholipid syndrome patients: A multicenter multiplatform study. Journal of Thrombosis and Haemostasis. 18(2). 463–478. 26 indexed citations

15.

Risse, Jessie, Damien Mandry, Nicla Settembre, et al.. (2016). Dramatic Response to Tocilizumab Before Emergency Surgery in Severe Active Takayasu Disease. Circulation Cardiovascular Imaging. 9(7). 7 indexed citations

16.

Zuily, Stéphane, Cecilia Beatrice Chighizola, Denis Wahl, Pier Luigi Meroni, & Doruk Erkan. (2015). Antiphospholipid Syndrome Alliance for Clinical Trials and International Networking Clinical Database and Repository Cluster Analysis : Identification of Different Clinical Phenotypes Among Antiphospholipid Antibody-Positive Female Patients. Arthritis & Rheumatism. 67. 1 indexed citations

17.

Zuily, Stéphane, Bas de Laat, Hilde Kelchtermans, et al.. (2015). Validity of the global anti-phospholipid syndrome score to predict thrombosis: a prospective multicentre cohort study. Lara D. Veeken. 54(11). 2071–2075. 48 indexed citations

18.

Zuily, Stéphane, J. Champigneulle, Valérie Eschwège, et al.. (2013). Le syndrome des antiphospholipides en néphrologie. Atteinte rénale et aspects pratiques de la prise en charge. Néphrologie & Thérapeutique. 10(1). 1–9. 1 indexed citations

19.

Zuily, Stéphane, Patrick Jourdain, Nelly Agrinier, et al.. (2010). Impact of heart failure management unit on heart failure-related readmission rate and mortality. Archives of cardiovascular diseases. 103(2). 90–96. 12 indexed citations

20.

Zuily, Stéphane, Christophe Goetz, Julien Rosencher, et al.. (2010). CAN THE SYNTAX SCORE BE USED IN CLINICAL PRACTICE? RESULTS OF A INTER- AND INTRA-OBSERVER VARIABILITY STUDY. Journal of the American College of Cardiology. 55(10). A134.E1258–A134.E1258. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact